GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Turmeric Acquisition Corp (NAS:TMPMU) » Definitions » Intangible Assets

Turmeric Acquisition (Turmeric Acquisition) Intangible Assets : $0.00 Mil (As of Jun. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Turmeric Acquisition Intangible Assets?

Intangible assets are defined as identifiable non-monetary assets that cannot be seen, touched or physically measured. Turmeric Acquisition's intangible assets for the quarter that ended in Jun. 2022 was $0.00 Mil.


Turmeric Acquisition Intangible Assets Historical Data

The historical data trend for Turmeric Acquisition's Intangible Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Turmeric Acquisition Intangible Assets Chart

Turmeric Acquisition Annual Data
Trend Dec20 Dec21
Intangible Assets
- -

Turmeric Acquisition Quarterly Data
Aug20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Intangible Assets Get a 7-Day Free Trial - - - - -

Turmeric Acquisition Intangible Assets Calculation

Intangible assets are defined as identifiable non-monetary assets that cannot be seen, touched or physically measured. Examples of intangible assets include trade secrets, copyrights, patents, trademarks. If a company acquires assets at the prices above the book value, it may carry goodwill on its balance sheet. Goodwill reflects the difference between the price the company paid and the book value of the assets.


Turmeric Acquisition  (NAS:TMPMU) Intangible Assets Explanation

If a company (company A) received a patent through their own work, though it has value, it does not show up on its balance sheet as an intangible asset. However, if company A sells this patent to company B, it will show up on company B's balance sheet as an intangible asset.

The same applies to brand names, trade secrets etc. For instance, Coca-Cola's brand is extremely valuable, but the brand does not appear on its balance sheet, because the brand was never acquired.

Some intangibles are amortized. Amortization is the depreciation of intangible assets.

Many intangibles are not amortized. They may still be written down when the company decides the asset is impaired.

Whenever you see an increase in goodwill over a number of years, you can assume it's because the company is out buying other businesses above book value. GOOD if buying businesses with durable competitive advantage.

If goodwill stays the same, the company when acquiring other companies is either paying less than book value or not acquiring. Businesses with moats never sell for less than book value.

Intangibles acquired are on balance sheet at fair value.

Internally developed brand names (Coke, Wrigleys, Band-Aid) however are not reflected on the balance sheet.

One of the reasons competitive advantage power can remain hidden for so long.


Be Aware

Companies may change the way intangible assets are amortized, and this will affect their reported earnings.


Turmeric Acquisition Intangible Assets Related Terms

Thank you for viewing the detailed overview of Turmeric Acquisition's Intangible Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Turmeric Acquisition (Turmeric Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
450 Kendall Street, Cambridge, MA, USA, 02142
Turmeric Acquisition Corp is a blank check company.
Executives
Luke Evnin officer: Chief Executive Officer THE JOHN HANCOCK TOWER, 200 CLARENDON STREET, 54TH STREET, BOSTON MA 02116
Mitchell H. Finer director C/O BLUEBIRD BIO, INC., 840 MEMORIAL DRIVE, CAMBRIDGE MA 02139
Edward Hurwitz officer: Chief Financial Officer
Todd Foley officer: President THE JOHN HANCOCK TOWER, 200 CLARENDON STREET 54TH FLOOR, BOSTON MA 02116
Pablo J Cagnoni director ONYX PHARMACEUTICALS, INC., 249 E. GRAND AVE., SOUTH SAN FRANCISCO CA 94080
David P Meeker director C/O PENWEST PHARMACEUTICALS CO, 39 OLD RIDGEBURY ROAD SUITE 11, DANBURY CT 06810
Andrew R Robbins director C/O 3200 WALNUT ST, BOULDER CO 80301
Matthew Roden director 450 KENDALL STREET, CAMBRIDGE MA 02142
Turmeric Management, Llc 10 percent owner 450 KENDALL STREET, CAMBRIDGE MA 02142
Vinay Bhaskar officer: Chief Operating Officer 2000 SIERRA POINT PARKWAY, SUITE 701, BRISBANE CA 94005